MeiraGTx Holdings (MGTX) Retained Earnings (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Retained Earnings of $2.4 million for Q4 2025, up 100.34% on a YoY basis from $1.2 million in Q4 2024, and up 100.29% quarter-over-quarter from -$831.3 million in Q3 2025.
MeiraGTx Holdings (MGTX) Retained Earnings (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Retained Earnings for 9 years, with the latest figure at $2.4 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings rose 100.34% year-over-year to $2.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.4 million (up 100.34% YoY), and the FY2025 full-year result was $2.4 million, up 100.34% from the prior year.
- Retained Earnings for Q4 2025 stood at $2.4 million, up from -$831.3 million in the prior quarter.
- The five-year high for Retained Earnings was $15.4 million in Q3 2022, with the low at -$831.3 million in Q3 2025.
- Historically, Retained Earnings has averaged -$226.2 million across 5 years, with a median of -$6.3 million in 2025.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 104.65% — and 2023, when it tumbled 67635.86%.
- MeiraGTx Holdings' Retained Earnings stood at -$2.7 million in 2021, then plunged by 17504.04% to -$470.2 million in 2022, then jumped by 99.69% to -$1.4 million in 2023, then sank by 48821.39% to -$702.0 million in 2024, then jumped by 100.34% to $2.4 million in 2025.
- The last three Retained Earnings figures came in at $2.4 million (Q4 2025), -$831.3 million (Q3 2025), and -$7.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 2.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.41 Mn |
| Sep 30, 2025 | -831.31 Mn |
| Jun 30, 2025 | -7.53 Mn |
| Mar 31, 2025 | -5.07 Mn |
| Dec 31, 2024 | -702.02 Mn |
| Sep 30, 2024 | -4.85 Mn |
| Jun 30, 2024 | -3.61 Mn |
| Mar 31, 2024 | -574.70 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Sep 30, 2023 | 7.16 Mn |
| Jun 30, 2023 | -530.15 Mn |
| Mar 31, 2023 | -500.57 Mn |
| Dec 31, 2022 | -470.20 Mn |
| Sep 30, 2022 | 15.39 Mn |
| Jun 30, 2022 | 6.62 Mn |
| Mar 31, 2022 | -739,000.00 |
| Dec 31, 2021 | -2.67 Mn |
| Sep 30, 2021 | -330.68 Mn |
| Jun 30, 2021 | -304.70 Mn |
| Mar 31, 2021 | -284.60 Mn |